Filter Results:
(555)
Show Results For
- All HBS Web
(555)
- People (4)
- News (149)
- Research (350)
- Events (2)
- Multimedia (4)
- Faculty Publications (168)
Show Results For
- All HBS Web
(555)
- People (4)
- News (149)
- Research (350)
- Events (2)
- Multimedia (4)
- Faculty Publications (168)
- 08 Nov 2016
- First Look
November 8, 2016
and models, with a specific focus on developments in and cooperation with China. Focusing on why this model responds to the twenty-first century requirements for excellence and relevance in undergraduate education, contributors examine if... View Details
Keywords: Sean Silverthorne
- 01 Dec 2013
- News
To Market, to Market
chirality) of drug molecules with a high degree of accuracy for drug development and diagnostic applications. Chemical compounds excreted by predators that stimulate avoidance... View Details
- 24 Sep 2020
- News
The Race for a Vaccine
newly opened facility to accommodate its vaccine development work, and CEO Stéphane Bancel (MBA 2000, AMP 170) welcomed input on the design from the government’s infectious disease experts. For two years, Moderna had been working closely... View Details
- 01 Dec 2013
- News
Your Own Medicine
million to have the biotech develop it as a potential cancer drug, eventually giving up when even low doses resulted in severe nausea during clinical trials. Still, the drug became a focal point for the... View Details
- Profile
Henry McCance
a few FDA-approved drugs for Alzheimer’s disease, and they won’t help,’” he recalls. McCance, a venture- capital pioneer with Greylock Partners, had spent 40 years as eyewitness to advances in technology that changed the world at... View Details
- 20 Aug 2014
- News
With No Time to Lose
into ALS research, and removed some critical barriers to the development of treatments. “Our focus, from the start, was to get drug companies to invest money in ALS,” says Kremer, who was diagnosed with the... View Details
Keywords: Margie Kelley
- 29 May 2001
- Research & Ideas
Genomics: Can We Start Making Money Now?
said. The potential influence on drug development in particular, and medicine in general, is enormous, panelists agreed. Today's drugs can reach some 400 to 500 potential... View Details
Keywords: by Sean Silverthorne
- 01 Jun 2009
- Lessons from the Classroom
The Challenges of Investing in Science-Based Innovation
she adds, with the development of a vaccine against cervical cancer (Gardasil) and the launch of successful new drugs to combat diabetes and HIV/AIDS. Sato acknowledges that different situations will require... View Details
- 08 Dec 2003
- Research & Ideas
Why Europe Lags in Pharmaceuticals and Biotech
pharma," said HBS professor Regina Herzlinger, moderating a panel discussion titled "Pharma and Biotech—Where does Europe Stand in the World?" The discussion was held at the conference on November 22. At the start of the 1990s, the U.S. and European... View Details
- 01 Jun 2000
- News
The Business of Biotech
"blockbusters" will disappear. Recent developments suggest that doctors will eventually be able to treat patients more effectively with medicine tailored to their genetic makeup, including, in some cases, gene replacement therapies. "The... View Details
Keywords: Julia Hanna
- 01 Mar 2016
- News
Off Script
(Thinkstock) Prescription drug spending increased by more than 13 percent in the United States in 2014, raising health insurance premiums and the ire of consumers and politicians. The reasons behind the rise are many, including the high... View Details
- 01 Jan 2009
- News
Kathryn E. Giusti, MBA 1985
aided in the development of drugs for this and other cancers. A successful marketing executive who had worked at Merck, Gillette, and Searle, Giusti was diagnosed with myeloma in 1996. As she faced a grim... View Details
- 13 Oct 2016
- News
Adding Muscle to the Fight Against Disease
graduation from Harvard Business School and which successfully developed and commercialized a market-leading drug to treat cardiovascular disease. But in addition to drawing on technical degrees and... View Details
Keywords: Deborah Blagg
John W. Culligan
Culligan capped off a 49-year career with American Home Products as its CEO from 1981 to 1986. During his tenure he doubled AHP’s research & development budget, building a pipeline of 24 new drugs and 48... View Details
Keywords: Healthcare
- 01 Sep 2004
- News
American Dream
visitors in their tracks. “I wonder if I should turn him down a little,” Hustead muses. As president of Wall Drug in Wall, South Dakota, Hustead ponders this and many other details of a 76,000-square-foot roadside attraction, not far from... View Details
- 04 Sep 2019
- News
Deep Dive
manage a worldwide team to develop a virtual product—diving to the bottom of all five oceans, and doing a lot of science along the way.” The Five Deeps Expedition, Vescovo said, has “proven to be as challenging as any business thing I’ve... View Details
- 01 Sep 2008
- News
Mara Aspinall
pharmaceutical companies focused their R&D on treatments for common illnesses — such as diabetes and high cholesterol — an approach that resulted in the development of blockbuster drugs. We now recognize that diseases are far more complex... View Details
Josiah K. Lilly
Lilly, a trained pharmacist and the founder of the family drug manufacturer, set up the first scientific division in the company and focused on standards of manufacturing and scientific development. Among other products, the company... View Details
Keywords: Healthcare
- Fast Answer
Pharmaceuticals: Pipeline
Profiles cover detailed information such as alternative names, therapeutic uses, FDA actions and licensing changes, companies associated with development of the drug, etc. To begin a search, use the function BI PHRM DEX, select... View Details
- 07 Oct 2014
- News
Network Effect
was shocked by their advice. “They said, ‘Try three Advil a day. It might help. There are a few FDA-approved drugs for Alzheimer’s disease, and they won’t help,’” he recalls. McCance, a venture- capital pioneer with Greylock Partners, had... View Details
Keywords: Linda Kush